January 15th 2021, 9:30pm
Florida Cancer Specialists has integrated SpaceOAR Hydrogel into its armamentarium as a pre-treatment for radiation therapy in prostate cancer patients.
January 9th 2021, 9:15pm
Daniel F. Hayes, MD, offers definitions and an algorithm for clinicians to define clinical utility.
January 9th 2021, 2:52am
The findings could lead to a precision medicine approach to prostate cancer screening.
December 31st 2020, 1:00pm
Neeraj Agarwal, MD, University of Utah Huntsman Cancer Institute, discusses knowledge gaps and the importance of genomic testing in prostate cancer.
December 24th 2020, 3:00pm
Neeraj Agarwal, MD, University of Utah Huntsman Cancer Institute, shares his experience regarding the prostate cancer patients who could potentially benefit from PARP inhibition.
December 22nd 2020, 3:26pm
Congress passes legislation that will delay the start of the Radiation Oncology (RO) Advanced Payment Model; examining the newly identified variant of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19); a study finds Hispanics and those without college degrees most subject to excess death during pandemic.
December 16th 2020, 2:54pm
Samples show certain subgroups of men with prostate cancer are more receptive to radiation therapy; FDA grants emergency use authorization to an at-home coronavirus disease 2019 (COVID-19) test; Anthony Fauci, MD, says COVID-19 herd immunity is possible by spring 2021.
December 15th 2020, 9:00pm
Neeraj Agarwal, MD, a clinician and researcher at the University of Utah Huntsman Cancer Institute, discusses investigational combinations with PARP inhibitors in prostate cancer treatment.
December 12th 2020, 4:00pm
The genes are part of the family that cause cancer cells to grow.
December 11th 2020, 3:30pm
Neeraj Agarwal, MD, of the University of Utah's Huntsman Cancer Institute, discusses ongoing trials of PARP inhibitors as first-line metastatic prostate cancer treatments.
